Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda approval symbols : Abbv save search
RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2022-03-16 (Crawled : 22:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.72%
H: 0.92%
C: 0.9%
rinvoq treatment fda fda approval approval active ulcerative colitis
RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Active Psoriatic Arthritis
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
rinvoq fda fda approval approval
New Relief for Migraine Sufferers as FDA Approves AbbVie's Atogepant
Published: 2021-09-29 (Crawled : 16:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.48%
H: 1.6%
C: 0.92%
fda migraine approval fda approval
FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine
Published: 2021-09-28 (Crawled : 00:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.48%
H: 1.6%
C: 0.92%
treatment fda migraine fda approval
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
fda fda approval
DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
Published: 2021-07-23 (Crawled : 17:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
fda fda approval skin approval injection infections
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
Published: 2021-02-25 (Crawled : 01:10) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.19%
H: 0.76%
C: -1.06%
fda fda approval approval ulcerative colitis
BOTOX® (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition
Published: 2021-02-10 (Crawled : 15:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.55%
H: 0.14%
C: -1.82%
fda approval fda approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.